Table 1.

Clinical features of patients studied

CharacteristicNumber% of total
Age at surgery/years (range)62.9(23.8–76.0)
Gender
 Female1453.8%
 Male1246.2%
Karnofsky performance score
 80519.2%
 901869.2%
 100311.5%
Primary cancer
 Non–small cell lung1350%
 Breast415.4%
 Melanoma415.4%
 Colorectal27.7%
 Renal13.8%
 Other27.7%
Extracranial metastases
 Absent1869.2%
 Present830.8%
Control of primary disease
 Synchronous934.6%
 Controlled1765.4%
Adjuvant WBRT (30 Gy in 10#)
 No519.2%
 Yes2180.8%
Adjuvant chemotherapy
 None1350.0%
 Yes934.6%
 Targeted agent415.4%
OS/months (range)5.8(1.6–15.5)
Intracranial progression
 None1661.5%
 Local726.9%
 Distant311.5%
Progression-free survival/months (range)3.8(0.2–12.9)